Urinary carnitine excretion in patients with heart failure

To evaluate the fatty acid metabolism in heart failure, the semiquantitative analysis of urinary free carnitine and acylcarnitine was made by fast atom bombardment mass spectrometry (FABMS) in 22 patients (mean age 67.3 years) with heart failure and 19 age‐matched healthy controls (average age 60.4 years). Urinary excretion of free carnitine was 0.20 ± 0.118 ratio/mg creatinine in the healthy controls and 1.32 ± 1.170 ratio/mg creatinine in the patients with heart failure. The latter value was significantly higher (p < 0.01 ). Patients with heart failure were classified into two groups according to the urinary free carnitine concentration. One was the high excretion group (2.19 ± 0.102 ratio/mg creatinine, 12 cases) and the other was the low excretion group (0.37 ± 0.212 ratio/mg creatinine, 10 cases). In the high excretion group, urinary acetylcarnitine was also increased, but no significant abnormalities were observed in the urinary organic acid profile. In the high group, 1 patient was classified as NYHA class III and 11 as NYHA class IV. Four patients died in the hospital. In the low excretion group, five patients were classified as NYHA class III and five as NYHA class IV. Only one patient died in the hospital. In the high group, patients with severe and prolonged heart failure tended to maintain higher values of urinary free carnitine. We could not find any abnormalities in fatty acid metabolism in patients with heart failure, but it is suspected that the patients who excrete large amounts of free carnitine into the urine, namely the patients with severe heart failure, have some possibility of carnitine deficiency.